Lexaria Bioscience Corp. Discusses The Importance of New Subsidiaries and Intellectual Property with Uptick Newswire’s Stock Day Podcast
October 23, 2018 09:00 ET
|
Lexaria Bioscience Corp
PHOENIX, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is a drug delivery platform innovator that has developed and out-licenses...
Chris Bunka, CEO of Lexaria Bioscience Corp., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Discuss New Products and Company Evolution
March 12, 2018 10:15 ET
|
Lexaria Bioscience Corp
Phoenix, March 12, 2018 (GLOBE NEWSWIRE) -- Phoenix, AZ – March 13, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, today...
Uptick Newswire “Stock Day” Interviews CEO of Lexaria on Cannabis Related Products and Recent Bioscience Patents
December 18, 2017 08:00 ET
|
Lexaria Bioscience Corp
Phoenix, AZ, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has...
Lexaria Bioscience Files Innovative New Patent Application
November 09, 2017 08:02 ET
|
Lexaria Bioscience Corp
KELOWNA, British Columbia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has filed a...
Lexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECH™ Delivery of THC, NSAIDs, Nicotine and Vitamins.
October 31, 2017 16:48 ET
|
Lexaria Bioscience Corp
KELOWNA, British Columbia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has...
University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria's TurboCBD(TM)
August 31, 2017 07:55 ET
|
Lexaria Bioscience Corp
KELOWNA, BC--(Marketwired - August 31, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the world's first clinical study on...
CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress
August 10, 2017 09:00 ET
|
Lexaria Bioscience Corp
Kelowna, BC , Aug. 10, 2017 (GLOBE NEWSWIRE) -- CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress Kelowna, BC (UPTICK Newswire – August 10, 2017) -...
National Research Council and Lexaria Bioscience Commence Laboratory Work
July 20, 2017 08:00 ET
|
Lexaria Bioscience Corp
KELOWNA, BC--(Marketwired - July 20, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the start of laboratory work under its...
Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles
July 18, 2017 08:00 ET
|
Lexaria Bioscience Corp
KELOWNA, BC--(Marketwired - July 18, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that the Australian Patent Office has granted patent...
Lexaria Files New Patent Application
June 22, 2017 08:00 ET
|
Lexaria Bioscience Corp
VANCOUVER, BC--(Marketwired - June 22, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces the filing of a new provisional patent application and stock...